Rheumatic diseases and portal hypertension
- VernacularTitle:风湿性疾病与门静脉高压
- Author:
Li SHEN
1
;
Weijia DUAN
1
;
Tingting LYU
1
;
Jidong JIA
1
Author Information
- Publication Type:Journal Article
- Keywords: Rheumatic Diseases; Portal Hypertension; Diagnosis
- From: Journal of Clinical Hepatology 2025;41(5):812-816
- CountryChina
- Language:Chinese
- Abstract: Rheumatic diseases are a group of chronic disorders characterized by abnormalities in the immune system， while portal hypertension occurs due to increased blood flow or heightened resistance in the portal venous system or obstruction of hepatic venous outflow. Both rheumatic diseases and their medications can lead to noncirrhotic portal hypertension. The hypercoagulable state associated with rheumatic diseases can result in thrombosis within the portal and hepatic venous systems， and damage to the intrahepatic portal system and hepatic sinusoidal endothelial system can lead to porto-sinusoidal vascular disease and hepatic sinusoidal obstruction syndrome. Moreover， drugs used for the treatment of rheumatic diseases may cause liver parenchymal injury， which further leads to liver fibrosis and cirrhosis， or they may damage the hepatic vascular endothelium and thus cause noncirrhotic portal hypertension. This article elaborates on the mechanisms and characteristics by which common rheumatic diseases and their therapeutic agents lead to portal hypertension， in order to provide insights and assistance for clinical diagnosis， treatment， and follow-up monitoring.
